Systematic review of antidepressant therapies in Parkinson's disease *

By Chung T.H.   Deane K.H.O.   Ghazi-Noori S.   Rickards H.   Clarke C.E.  

Parkinsonism and Related Disorders, Vol. 10, Iss. 2, 2003-12 ,pp. : 59-65

Elsevier

Access to resources Recommend Favorite

Parkinson's disease, insulin resistance and novel agents of neuroprotection

By Aviles-Olmos Iciar  

Brain, Vol. 136, Iss. 2, 2013-02 ,pp. : 374-384

Oxford University Press

Access to resources Recommend Favorite

Parkinson's Disease: The Case for Novel Treatment Strategies

By Stern M.B.   Freese A.  

Experimental Neurology, Vol. 144, Iss. 1, 1997-03 ,pp. : 2-3

Elsevier

Access to resources Recommend Favorite

A novel screen for nuclear mitochondrial gene associations with Parkinson’s disease

By Mellick G. D.   Silburn P. A.   Prince J. A.   Brookes A. J.  

Journal of Neural Transmission, Vol. 111, Iss. 2, 2004-02 ,pp. : 191-199

Springer Publishing Company

Access to resources Recommend Favorite

Nonpharmacological therapies for cognitive enhancement in Parkinson’s disease: applying old interventions in a new setting?

By Sindhi Amit   Leroi Iracema  

Neurodegenerative Disease Management, Vol. 3, Iss. 6, 2013-12 ,pp. : 539-547

Future Medicine

Access to resources Recommend Favorite